The top executive of Indian multinational pharmaceutical company, Lupin, shares the various initiatives the company has undertaken to support the frontline healthcare workers in the US during the pandemic.
The Indian Pharmaceutical Industry stands the third in terms of volume and 4th in value terms. The global medicine market got more and more attractive. The global markets though critical for Indian companies, proved to be a go to for Indian generic drugs makers and breakthrough inventions in 2015. ‘India Global Business’ presents some of the highlights of this year’s activity in the pharma sector. Lupin launches diabetes drug in US Indian drug-maker Lupin’s US subsidiary, Lupin Pharmaceuticals Inc, launched [...]